Cathie Wood: portfolio of ARK Investment Management

Cathie Wood leads ARK Investment Management, which offers actively managed funds focused on technology and innovation.

Source: 13F filing with the US Securities and Exchange Commission dated Jul 10, 2023. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q2 2023. Go to the latest filing (Q3 2026)

15.1B USDQ2 2023
Total value of stock positions
15.1B USD
Positions
222
Share of the ten largest
49.0%

The ten largest positions Q2 2023

  1. Tesla, Inc. 8.4%▼ −11.0%
  2. Coinbase 5.7%▲ +2.9%
  3. UiPath Inc 5.3%▲ +7.5%
  4. Roku Inc 5.1%▼ −4.2%
  5. Block, Inc. 4.7%▲ +2.4%
  6. Zoom Video Communications Inc 4.7%▼ −3.7%
  7. Exact Sciences Corp 4.4%▼ −37.1%
  8. Shopify 3.8%▼ −36.5%
  9. Unity Software Inc 3.4%▼ −3.0%
  10. Teladoc Health Inc 3.4%▼ −1.2%
Total value of stock positions per quarter, Q4 2016 to Q3 2026 (peak 53.7B USD).
Choose a quarter (40 filings)

All positions Q2 2023

Positions Q2 2023 per 13F filing, 50 of 135
Symbol Weight Shares Reported value Change Held since
TSLA Tesla, Inc. 8.4% 4,843,621 1.3B USD −11.0% reduced Q4 2016 or earlier 27 quarters
Roku Inc 5.1% 11,958,292 764.9M USD −4.2% reduced Q2 2019 17 quarters
Zoom Video Communications Inc 4.7% 10,462,306 710.2M USD −3.7% reduced Q4 2020 11 quarters
Exact Sciences Corp 4.4% 7,155,098 671.9M USD −37.1% reduced Q3 2020 12 quarters
SHOP Shopify 3.8% 8,874,796 573.3M USD −36.5% reduced Q2 2017 25 quarters
Unity Software Inc 3.4% 11,935,740 518.2M USD −3.0% reduced Q3 2020 12 quarters
Teladoc Health Inc 3.4% 20,344,101 515.1M USD −1.2% reduced Q3 2017 24 quarters
DKNG DraftKings 3.2% 18,060,463 479.9M USD −24.5% reduced Q1 2021 10 quarters
CRISPR Therapeutics AG 2.7% 7,338,447 412.0M USD −8.2% reduced Q2 2017 25 quarters
Intellia Therapeutics Inc 2.6% 9,525,931 388.5M USD −3.2% reduced Q4 2016 or earlier 27 quarters
Pacific Biosciences of Califor 2.3% 26,634,620 354.2M USD −4.0% reduced Q3 2019 16 quarters
Beam Therapeutics Inc 1.8% 8,382,595 267.7M USD −2.2% reduced Q4 2020 11 quarters
Veracyte Inc 1.3% 7,828,292 199.4M USD −6.9% reduced Q4 2016 or earlier 27 quarters
Schrodinger Inc/United States 1.2% 3,517,355 175.6M USD −10.0% reduced Q2 2020 13 quarters
10X Genomics Inc 1.2% 3,113,549 173.9M USD −25.1% reduced Q2 2020 13 quarters
Twist Bioscience Corp 0.9% 6,959,240 142.4M USD −3.1% reduced Q2 2019 17 quarters
NVDA Nvidia 0.8% 295,732 125.1M USD −28.6% reduced Q4 2016 or earlier 27 quarters
Grayscale Bitcoin Trust BTC 0.7% 5,820,591 111.7M USD −5.1% reduced Q4 2018 19 quarters
Ionis Pharmaceuticals Inc 0.7% 2,422,631 99.4M USD −8.1% reduced Q4 2016 or earlier 27 quarters
Accolade Inc 0.5% 5,683,906 76.6M USD −1.0% reduced Q3 2020 12 quarters
CareDx Inc 0.4% 6,638,350 56.4M USD −2.4% reduced Q2 2019 17 quarters
Arcturus Therapeutics Holdings 0.4% 1,906,996 54.7M USD −4.0% reduced Q2 2019 17 quarters
MELI MercadoLibre 0.3% 43,594 51.6M USD −26.7% reduced Q4 2016 or earlier 27 quarters
Cerus Corp 0.3% 20,657,391 50.8M USD −6.5% reduced Q4 2016 or earlier 27 quarters
DE Deere & Company 0.3% 117,018 47.4M USD −5.3% reduced Q3 2017 24 quarters
Global-e Online Ltd 0.3% 1,081,123 44.3M USD −8.2% reduced Q1 2022 6 quarters
Komatsu Ltd 0.3% 1,559,264 42.2M USD −0.1% reduced Q3 2019 16 quarters
VRTX Vertex Pharmaceuticals 0.3% 115,671 40.7M USD −4.0% reduced Q3 2020 12 quarters
VEEV Veeva Systems 0.3% 200,394 39.6M USD −3.9% reduced Q4 2020 11 quarters
Adyen NV 0.2% 21,551 37.3M USD −0.1% reduced Q1 2019 18 quarters
2U Inc 0.2% 8,783,754 35.4M USD −5.8% reduced Q4 2016 or earlier 27 quarters
INTU Intuit 0.2% 71,541 32.8M USD −0.1% reduced Q2 2017 25 quarters
BILL Holdings Inc 0.2% 276,201 32.3M USD −0.1% reduced Q1 2021 10 quarters
Discovery Ltd 0.2% 4,102,370 31.8M USD −0.1% reduced Q4 2019 15 quarters
Genius Sports Ltd 0.2% 5,088,781 31.5M USD −0.4% reduced Q3 2021 8 quarters
NU Nu Holdings (Class A) 0.2% 3,934,538 31.0M USD −7.8% reduced Q4 2021 7 quarters
INCY Incyte 0.2% 467,566 29.1M USD −35.8% reduced Q4 2016 or earlier 27 quarters
StoneCo Ltd 0.2% 2,240,437 28.5M USD −5.1% reduced Q2 2021 9 quarters
GOOG Alphabet Inc. (Class C) 0.2% 233,254 28.2M USD −2.5% reduced Q2 2020 13 quarters
Stratasys Ltd 0.2% 1,578,513 28.0M USD −12.1% reduced Q4 2016 or earlier 27 quarters
Repare Therapeutics Inc 0.2% 2,628,073 27.8M USD −4.0% reduced Q4 2020 11 quarters
908 Devices Inc 0.2% 3,972,905 27.3M USD −0.5% reduced Q4 2020 11 quarters
Elbit Systems Ltd 0.2% 118,897 24.8M USD −12.3% reduced Q4 2016 or earlier 27 quarters
ANSYS Inc 0.2% 74,407 24.6M USD −6.6% reduced Q4 2016 or earlier 27 quarters
REGN Regeneron Pharmaceuticals 0.2% 32,253 23.2M USD −4.0% reduced Q4 2020 11 quarters
Guardant Health Inc 0.1% 574,995 20.6M USD −1.4% reduced Q3 2022 4 quarters
Compass Pathways Plc 0.1% 2,439,580 20.2M USD −4.0% reduced Q3 2022 4 quarters
MSFT Microsoft 0.1% 58,969 20.1M USD −13.4% reduced Q4 2016 or earlier 27 quarters
ISRG Intuitive Surgical 0.1% 52,065 17.8M USD −8.6% reduced Q2 2018 21 quarters
MRNA Moderna 0.1% 142,998 17.4M USD −4.0% reduced Q3 2022 4 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Show more (up to 500) Shown: the 50 largest of 135 positions.

Breakdown by sector

  • Financials 12.6%
  • Consumer Discretionary 8.6%
  • Technology 7.4%
  • Health Care 1.3%
  • Industrials 1.2%
  • Communication Services 0.6%
  • not in our coverage 68.4%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close